XML 34 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Total IPO
Total Follow-On Offering
Common Shares
Common Shares
Total IPO
Common Shares
Total Follow-On Offering
Additional Paid-In Capital
Additional Paid-In Capital
Total IPO
Additional Paid-In Capital
Total Follow-On Offering
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2020 $ 136,003     $ 2     $ 183,015     $ (47,014)  
Beginning Balance (in shares) at Dec. 31, 2020       23,410,348              
Issuance of common stock upon completion of the initial public offering, net of underwriting discounts and commissions and offering costs (in shares)         7,130,000            
Issuance of common stock upon completion of the initial public offering, net of underwriting discounts and commissions and offering costs   $ 82,967     $ 1     $ 82,966      
Issuance of restricted common stock       1,589,622              
Share-based compensation expense 3,645           3,645        
Net loss (47,013)                 (47,013)  
Other comprehensive loss 0                    
Ending Balance (in shares) at Dec. 31, 2021       32,129,970              
Ending Balance at Dec. 31, 2021 175,602     $ 3     269,626     (94,027)  
Issuance of common stock and pre-funded warrants upon completion of the follow-on offering, net of underwriting discounts and commissions and offering costs (in shares)           5,803,655          
Issuance of common stock and pre-funded warrants upon completion of the follow-on offering, net of underwriting discounts and commissions and offering costs     $ 50,846     $ 1     $ 50,845    
Share-based compensation expense 9,499           9,499        
Net loss (66,654)                 (66,654)  
Issuance of common stock from the stock purchase plan (in shares)       38,845              
Issuance of common stock from the stock purchase plan $ 217           217        
Issuance of common stock from the stock award plan, vested (in shares)       2,000              
Forfeiture of restricted common stock, shares       (139,115)              
Options exercised - shares 2,014     2,014              
Issuance of common stock from exercise of stock options $ 21           21        
Other comprehensive loss (214)                   $ (214)
Ending Balance (in shares) at Dec. 31, 2022       37,837,369              
Ending Balance at Dec. 31, 2022 $ 169,317     $ 4     $ 330,208     $ (160,681) $ (214)